Publications by authors named "Christopher Rudd"

Claim this Profile
A
Author Correction: SKAP-55 regulates integrin adhesion and formation of T cell-APC conjugates.
Hongyan Wang, Eun-Yi Moon, Abdallah Azouz, Xiang Wu, Andrew Smith, Christopher E Rudd

Nat Immunol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4/CD8-p56 Induced T-Cell Receptor Signaling and Its Implications for Immunotherapy.
Andres Oroya, Christopher E Rudd

Biomolecules· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comment on: Glycogen synthase kinase 3 controls T-cell exhaustion by regulating NFAT activation.
Bastien Moës, Christopher E Rudd

Cell Mol Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune cell infiltration into brain tumor microenvironment is mediated by Rab27-regulated vascular wall integrity.
Lata Adnani, Brian Meehan, Minjun Kim, Dongsic Choi, Christopher E Rudd

Sci Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GSK-3 regulates CD4-CD8 cooperation needed to generate super-armed CD8+ cytolytic T cells against tumors.
Bastien Moës, Janna Krueger, Alexandra Kazanova, Chen Liu, Yunfeng Gao, Christopher E Rudd

bioRxiv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The identification of a SARs-CoV2 S2 protein derived peptide with super-antigen-like stimulatory properties on T-cells.
Thai Hien Tu, Fatima Ezzahra Bennani, Nasser Masroori, Chen Liu, Atena Nemati, Christopher E Rudd

Commun Biol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The identification of a SARs-CoV2 S2 protein-derived peptide with super-antigen-like stimulatory properties on T-cells.
Thai Hien Tu, Fatima Ezzahra Bennani, Nasser Masroori, Chen Liu, Atena Nemati, Christopher Rudd

bioRxiv· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1 endocytosis unleashes the cytolytic potential of checkpoint blockade in tumor immunity.
Elham Ben Saad, Andres Oroya, Nikhil Ponnoor Anto, Meriem Bachais, Christopher E Rudd

Cell Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-PTHrP blockade limits CD8+ T-cell exhaustion in anti-cancer immunotherapy.
Bastien Moës, Yunfeng Gao, Ekaterina Demina, Richard Kremer, Christopher E Rudd

bioRxiv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.
Fan Huang, Christophe Gonçalves, Margarita Bartish, Joelle Rémy-Sarrazin, Mark E Issa, Christopher E Rudd

J Clin Invest· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased progenitor TCF1 + T-cells correlate with COVID-19 disease severity.
Thai Hien Tu, Ami Grunbaum, François Santinon, Alexandra Kazanova, Nicholas Rozza, Christopher E Rudd

Commun Biol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: CEACAM1 regulates TIM-3-mediated tolerance and exhaustion.
Yu-Hwa Huang, Chen Zhu, Yasuyuki Kondo, Ana C Anderson, Amit Gandhi, Christopher E Rudd

Nature· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The many faceted role of glycogen synthase kinase-3 (GSK-3) in T cells and cancer immunotherapy.
Aurora Rivas Crespo, Silvia Guil Luna, Bastien Moës, Antonio Rodriguez, Christopher E Rudd

J Cancer Biol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of glycogen synthase kinase 3 (GSK-3) expression and tumor budding grade in colorectal cancer: Implications for targeted therapy.
Silvia Guil-Luna, Aurora Rivas-Crespo, Carmen Navarrete-Sirvent, Ana Mantrana, Alejandra Pera, Christopher E Rudd

Biomed Pharmacother· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD8 T cell killing of MHC class I-deficient tumors.
Christopher E Rudd

Nat Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting EGFR, RSK1, RAF1, PARP2 and LIN28B for several cancer type therapies with newly synthesized pyrazole derivatives via a computational study.
Fatima Ezzahra Bennani, Latifa Doudach, Khalid Karrouchi, Abdelilah Tarib, Christopher E Rudd

J Biomol Struct Dyn· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-functional adaptor SKAP1: regulator of integrin activation, the stop-signal, and the proliferation of T cells.
Chen Liu, Monika Raab, Yirui Gui, Christopher E Rudd

Front Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blasts in context: the impact of the immune environment on acute myeloid leukemia prognosis and treatment.
Yasmina Serroukh, Josée Hébert, Lambert Busque, François Mercier, Christopher E Rudd

Blood Rev· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct AKT activation in tumor-infiltrating lymphocytes markedly increases interferon-γ (IFN-γ) for the regression of tumors resistant to PD-1 checkpoint blockade.
François Santinon, Bennani Fatima Ezzahra, Meriem Bachais, Alain Sarabia Pacis, Christopher E Rudd

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Silico Identification of Promising New Pyrazole Derivative-Based Small Molecules for Modulating CRMP2, C-RAF, CYP17, VEGFR, C-KIT, and HDAC-Application towards Cancer Therapeutics.
Fatima Ezzahra Bennani, Khalid Karrouchi, Latifa Doudach, Mario Scrima, Noor Rahman, Christopher E Rudd

Curr Issues Mol Biol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms orchestrating the enzymatic activity and cellular functions of deubiquitinases.
Benjamin Estavoyer, Clémence Messmer, Mohamed Echbicheb, Christopher E Rudd, Eric Milot

J Biol Chem· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and prediction of novel pyrazole derivatives as potential anti-cancer compounds based on 2D-2D-QSAR study against PC-3, B16F10, K562, MDA-MB-231, A2780, ACHN and NUGC cancer cell lines.
Fatima Ezzahra Bennani, Latifa Doudach, Khalid Karrouchi, Youssef El Rhayam, Christopher E Rudd

Heliyon· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: T-Cell Signaling Networks in Health and Disease.
Christopher E Rudd, Isabel Merida, William Hawse

Front Immunol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective chimeric antigen receptor T cells against SARS-CoV-2.
Xueyang Guo, Alexandra Kazanova, Stephanie Thurmond, H Uri Saragovi, Christopher E Rudd

iScience· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.
Janna Krueger, Francois Santinon, Alexandra Kazanova, Mark E Issa, Bruno Larrivee, Christopher E Rudd

PLoS One· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis